Molecular Correlates of Parkinson?s Disease
Parkinson’s disease (PD) is a neurodegenerative disorder that is characterized by a progressive loss of dopamine-producing brain cells, leading to impaired movement and coordination, as well as a range of other symptoms. Molecular correlates of PD provide important insights into the underlying cause of the disease, and can be used to develop better treatments, such as gene therapy and other potential therapies. Molecular correlates may include changes in gene expression, changes in protein production, and changes in enzyme activity, as well as changes in other molecules that can be used to diagnose and monitor the progression of the disease. Additionally, molecular correlates have been used to identify novel drug targets and to design novel potential therapies for PD. Understanding the molecular mechanisms of PD is essential for refining existing treatments and for developing new strategies for managing the disease.
← Journal of Woman's Mental Health